Posts Tagged
‘Strategy’

January 4, 2022

|

by: admin

|

Tags: Called, FDAs, Omicron, Question, Strategy, Surges, Vaccine

|

Categories: autism

In other words, from a risk-benefit perspective, it is more logical to continue infusing monoclonal antibodies, even if they are only marginally effective, and to discontinue childhood vaccinations immediately. The CDC and FDA’s mystifying position can only be the result of their systematic rejection of any possibility of adverse vaccine events, despite the vast and […]